August 28th 2024
Compared with available literature, the rates of medication-related osteonecrosis of the jaw were higher in patients with breast cancer and bone metastases treated with antiresorptive therapy.
Understanding the Mechanism of Action Behind PARP Inhibitors for Prostate Cancer
Tools to Monitor for ICANS During Lymphoma Treatment With Bispecific Antibodies, CAR T-Cell Therapy
‘Bringing Every Single Resource’ When Caring for Patients Receiving Treatment for Gynecologic Cancers
Bringing DEI to Clinical Trial, Cancer Clinics Through Self-Awareness